Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NVP-BKM120 shows potential in models of follicular lymphoma

July 20, 2012

Novel BACE inhibitor shows promise to treat Alzheimer's disease

July 20, 2012

Scientists in China links gene's expression levels to severity of cognitive impairment

July 20, 2012

New S100-A4-neutralizing antibody is a potential therapy and biomarker for cancer

July 19, 2012

First clinical trials assess TOL-101 for preventing kidney transplant rejection

July 19, 2012

Novel product reduces accumulation of oligomeric beta-amyloid in brain

July 19, 2012

First clinical data disclosed on new beta-secretase 1 inhibitor for Alzheimer's disease

July 19, 2012

U.S. scientists develop new model of early-onset Alzheimer's disease

July 18, 2012

Phase II results presented on insulin analogue for diabetes

July 18, 2012

New candidate biomarker for prostate cancer discovered

July 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...